Skip to Content Skip to Main Navigation Skip to Local Navigation Skip to Search

Decrease the text size Increase the text size Print this page

AusPAR: Sevelamer carbonate

Related information

How to access a pdf or Word document

Australian Public Assessment Report

27 October 2015

AusPAR Details
AusPAR	AusPAR: Sevelamer carbonate (pdf, 977 KB) AusPAR: Sevelamer carbonate (docx, 1 MB) Attachment: Product Information: Sevelamer carbonate (Renvela) (pdf, 227 KB) Attachment: Product Information: Sevelamer carbonate (Renvela) (docx, 131 KB) Attachment: Product Information: Sevelamer carbonate (Sevelamer carbonate sanofi) (pdf, 283 KB) Attachment: Product Information: Sevelamer carbonate (Sevelamer carbonate sanofi) (docx, 130 KB) Attachment: Product Information: Sevelamer carbonate (Sevelamer carbonate winthrop) (pdf, 279 KB) Attachment: Product Information: Sevelamer carbonate (Sevelamer carbonate winthrop) (docx, 130 KB) Attachment: Extract from Clinical Evaluation Report: Sevelamer carbonate (pdf, 4 MB) Attachment: Extract from Clinical Evaluation Report: Sevelamer carbonate (docx, 8 MB)
Active Ingredient	Sevelamer carbonate
Product Name	Renvela / Sevelamer Carbonate Winthrop / Sevelamer Carbonate Sanofi
Sponsor	Sanofi-Aventis Australia Pty Ltd
Submission Number	PM-2013-04961-1-3
Submission Type	New chemical entity
Decision	Approved
AusPAR Date	2 October 2015
Publication Date	27 October 2015

Category:

Prescription medicines

Tags:

AusPARs

URL:

https://www.tga.gov.au/node/710685